Cancer Research UK Centre for Drug Development
Cancer Research UK's Centre for Drug Development is the partner of choice for early-phase cancer drug development. Through clinical development collaborations with Cancer Research Horizons, the academic and biopharma sectors across the globe can access its unique infrastructure to realise the full potential of their research.
>30
years of experience
~20
agents under active development
6
agents registered as medicines to date
Why work with the Centre for Drug Development?
With a team of over 100 drug development scientists and operational staff, their expertise spans preclinical and medical sciences, regulatory affairs, quality assurance, project management, drug safety, clinical operations and data management.
Their goal is to see scientific breakthroughs bring benefits to patients sooner. Priority targets include:
- First-in-class therapies
- First-in-human clinical trials
